oAlert.pl

Recalled Medicines & supplements – Current GIS Alerts 2026

Found 698 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.

Common hazards in this category

All recalled products

Lorabex – recalled product

Lorabex

CRITICAL 16.02.2023

Suspected quality defect: out-of-specification (OOS) results for the parameters Lorazepam content and Lorazepam related substances, which may indicate an incorrect amount of active substance and impurities in the solution for injection. Potential effects: lack of treatment efficacy, excessive sedative effect, adverse reactions, complications.

Diprophos – recalled product

Diprophos

CRITICAL 31.01.2023

Possible occurrence of brown, metallic-looking particles in the suspension for injection, identified as stainless steel particles, which may cause local inflammatory conditions and hypersensitivity reactions at the injection site. Potential effects: local complications, inflammation, allergic reactions, post-procedural complications.

Diprophos – recalled product

Diprophos

CRITICAL 31.01.2023

A possible occurrence of brown particles with a metallic appearance, identified as stainless steel particles, was found in the suspension for injection. Potential effects: local inflammatory reactions, hypersensitivity, complications after injection of foreign bodies.

Bupicain – recalled product

Bupicain

CRITICAL 27.01.2023

The information leaflet for Bupicain contains incorrect data on the possibility of intravenous and intra-arterial administration of the medicine, which is associated with a threat to public health. Potential effects: incorrect administration, severe complications, life-threatening events.

Febrisan – recalled product

Febrisan

MEDIUM 26.01.2023

An out-of-specification result was found in stability testing: at 12 months the content limits for paracetamol and ascorbic acid were exceeded; it is uncertain whether the rest of the batch meets quality requirements for active substance content. Potential effects: reduced treatment efficacy or increased adverse effects.

Bupivacaine Hydrochloride in Dextrose Injection USP – recalled product

Bupivacaine Hydrochloride in Dextrose Injection USP

CRITICAL 10.01.2023

The defective ampoule may crumble, creating a risk of glass particles entering the anaesthetic solution administered to the patient and of being unable to use the medicine during surgery. Potential effects: tissue damage from glass, surgical complications, life-threatening risk, lack of effective anaesthesia.

Allergovit – recalled product

Allergovit

CRITICAL 10.01.2023

Because there is a risk of misleading medical staff and, consequently, the patient receiving too high a dose of the drug, which may result in a threat to patients’ life and health. Potential effects: life‑threatening reactions, severe allergic reactions, serious complications of therapy.

HERBS, Thyme and Coltsfoot – recalled product

HERBS, Thyme and Coltsfoot

CRITICAL 30.12.2022

Exceeded permissible level of pyrrolizidine alkaloids in the dietary supplement (batch 31722). Potential effects: liver damage, toxicity with prolonged consumption.

BOOSTERON HARDCORE TESTOSTERONE BOOSTER (120 capsules) – recalled product

BOOSTERON HARDCORE TESTOSTERONE BOOSTER (120 capsules)

HIGH 14.12.2022

Presence of undeclared substances: yohimbine and ibutamoren, which may cause serious adverse effects and hormonal disturbances. Potential effects: adverse reactions, heart rhythm disorders, hypertension, hormonal disturbances.

MMASTER Raspberry – pre-workout supplement – recalled product

MMASTER Raspberry – pre-workout supplement

HIGH 13.12.2022

Presence of undeclared yohimbine — an alkaloid from yohimbe bark banned in food. Potential effects: cardiovascular disturbances, hypertension, tachycardia, neuropsychiatric symptoms, risk of poisoning.

Allergovit – recalled product

Allergovit

CRITICAL 09.12.2022

Incorrect labeling of vials (concentration A-1000 TU/ml labeled as B-10,000 TU/ml) may mislead medical staff and result in administering too high a dose, endangering patients’ life and health. Potential effects: overdose, severe allergic reactions, serious complications, life-threatening conditions.

Bisoratio ASA – recalled product

Bisoratio ASA

MEDIUM 07.12.2022

An out-of-specification result was found in stability testing for the parameter bisoprolol fumarate related substances: another single impurity. The probability of adverse reactions after exposure to the product cannot be excluded. Potential effects: possible adverse reactions, including toxic symptoms or reduced treatment efficacy.

Rivanol 0,1% – recalled product

Rivanol 0,1%

CRITICAL 05.12.2022

An out-of-specification pH value was detected, which may affect the antibacterial activity of ethacridine. A defective series of glass bottles is the probable cause, and pH changes until expiry are unpredictable. Potential effects: lack of treatment efficacy, possible complications of infections.

Cernevit – recalled product

Cernevit

CRITICAL 29.11.2022

An abnormal color of the solution after preparation was found, which may result from leaks caused by scratches on vial necks and lead to increased organic impurities or degradation products exceeding toxicological qualifications. Potential effects: toxic drug effects, parenteral complications, risk to patient health.

Tobramycin B. Braun – recalled product

Tobramycin B. Braun

CRITICAL 17.11.2022

It showed an out-of-specification result for the solution colour parameter. The product risk was assessed as RAS class II. Potential effects: possible reduced medicinal product quality, risk of treatment inefficacy or adverse reactions.

TESTOLONE – recalled product

TESTOLONE

HIGH 16.11.2022

Presence of undeclared ostarine and ibutamoren; declared RAD-140 not detected is also banned. Potential effects: pharmacological effects and adverse reactions.

BOSS Energy, dietary supplement – recalled product

BOSS Energy, dietary supplement

HIGH 10.11.2022

Presence of sildenafil and tadalafil, pharmacologically active substances not permitted in dietary supplements. Potential effects: pharmacological adverse effects, drug interactions, and risk to people with cardiac conditions.

Anacaps Expert – recalled product

Anacaps Expert

CRITICAL 28.10.2022

Possible contamination by glass particles in one of the product's ingredients. Potential effects: injuries to the mouth and gastrointestinal tract, risk of cuts and complications.

Fluorouracil Accord – recalled product

Fluorouracil Accord

CRITICAL 14.10.2022

Contaminants were detected in vials of batch P2108035, indicating possible non-compliance with quality requirements and a potential risk to patients’ health. Potential effects: treatment complications, infections, lack of therapeutic efficacy.

Mupina – recalled product

Mupina

HIGH 06.10.2022

detection during stability studies of out-of-specification results regarding an unknown impurity… it cannot be ruled out that keeping this product on the market may pose a risk to patient health. Potential effects: unknown adverse reactions, possible risk to patients’ health.

What to do if you bought a recalled product?

If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.